Race, hospital, insurance status all factors in how lung cancer is treated

African Americans, Hispanics, and those who receive care at a community hospital are all significantly less likely than other patients to receive treatment for early stage non-small cell lung cancer, according to a report in the¬†Journal of Thoracic Oncology. "We found significant disparities for treatment of a curable cancer based on race, insurance status, and … Continue reading Race, hospital, insurance status all factors in how lung cancer is treated

Advertisements

Increased overall survival for advanced stage non-small cell lung cancer patients is associated with availability of less toxic chemotherapy

A 10-year population-based study shows that increased availability of better systemic chemo- and targeted-therapies for patients with advanced non-small cell lung cancer (NSCLC) coincides with increased usage of these therapies. This in turn leads to a significant increase in overall survival. Researchers from the British Columbia Cancer Agency, Vancouver, Canada, performed a retrospective chart review … Continue reading Increased overall survival for advanced stage non-small cell lung cancer patients is associated with availability of less toxic chemotherapy

Survey sheds light on common clinical practice for incompletely resected lung cancer

A landmark survey of more than 700 specialists provides crucial real-world insight into the treatments most oncologists choose for lung cancer patients whose tumour has been incompletely resected, an expert from the European Society for Medical Oncology (ESMO) says. Jean Yves Douillard, from the ICO Institut de Cancerologie de l'Ouest Ren√© Gauducheau, France, Chair of … Continue reading Survey sheds light on common clinical practice for incompletely resected lung cancer

Hormone therapy linked to better survival after lung cancer diagnosis in women

Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival. The study … Continue reading Hormone therapy linked to better survival after lung cancer diagnosis in women